Becton, Dickinson and Company (BDX)
NYSE: BDX · Real-Time Price · USD
163.88
-0.53 (-0.32%)
At close: Mar 10, 2026, 4:00 PM EDT
163.88
0.00 (0.00%)
After-hours: Mar 10, 2026, 7:00 PM EDT

BDX Revenue

Becton, Dickinson and Company had revenue of $5.25B in the quarter ending December 31, 2025, with 1.63% growth. This brings the company's revenue in the last twelve months to $21.92B, up 6.22% year-over-year. In the fiscal year ending September 30, 2025, Becton, Dickinson and Company had annual revenue of $21.84B with 8.24% growth.

Revenue (ttm)
$21.92B
Revenue Growth
+6.22%
P/S Ratio
2.13
Revenue / Employee
$304,500
Employees
72,000
Market Cap
46.66B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 202521.84B1.66B8.24%
Sep 30, 202420.18B806.00M4.16%
Sep 30, 202319.37B502.00M2.66%
Sep 30, 202218.87B-261.00M-1.36%
Sep 30, 202119.13B3.06B19.02%
Sep 30, 202016.07B-1.22B-7.03%
Sep 30, 201917.29B1.31B8.18%
Sep 30, 201815.98B3.89B32.17%
Sep 30, 201712.09B-390.00M-3.12%
Sep 30, 201612.48B2.20B21.41%
Sep 30, 201510.28B1.84B21.74%
Sep 30, 20148.45B392.00M4.87%
Sep 30, 20138.05B346.00M4.49%
Sep 30, 20127.71B124.00M1.64%
Sep 30, 20117.58B459.62M6.45%
Sep 30, 20107.12B137.66M1.97%
Sep 30, 20096.99B89.10M1.29%
Sep 30, 20086.90B614.78M9.79%
Sep 30, 20076.28B544.82M9.49%
Sep 30, 20065.74B397.18M7.44%
Sep 30, 20055.34B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Medline28.43B
Baxter International11.24B
Alcon10.40B
Intuitive Surgical10.06B
Solventum8.33B
ResMed5.40B
The Cooper Companies4.15B
Hologic4.13B
Revenue Rankings